Literature DB >> 24036209

Regulation of fetal gene expression in heart failure.

Ellen Dirkx1, Paula A da Costa Martins, Leon J De Windt.   

Abstract

During the processes leading to adverse cardiac remodeling and heart failure, cardiomyocytes react to neurohumoral stimuli and biomechanical stress by activating pathways that induce pathological hypertrophy. The gene expression patterns and molecular changes observed during cardiac hypertrophic remodeling bare resemblance to those observed during fetal cardiac development. The re-activation of fetal genes in the adult failing heart is a complex biological process that involves transcriptional, posttranscriptional and epigenetic regulation of the cardiac genome. In this review, the mechanistic actions of transcription factors, microRNAs and chromatin remodeling processes in regulating fetal gene expression in heart failure are discussed.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epigenetics; Gene regulation; Transcription factors

Mesh:

Substances:

Year:  2013        PMID: 24036209     DOI: 10.1016/j.bbadis.2013.07.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  95 in total

1.  Calcium-mediated histone modifications regulate alternative splicing in cardiomyocytes.

Authors:  Alok Sharma; Hieu Nguyen; Cuiyu Geng; Melissa N Hinman; Guangbin Luo; Hua Lou
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

2.  CaM kinase II regulates cardiac hemoglobin expression through histone phosphorylation upon sympathetic activation.

Authors:  Ali Reza Saadatmand; Viviana Sramek; Silvio Weber; Daniel Finke; Matthias Dewenter; Carsten Sticht; Norbert Gretz; Till Wüstemann; Marco Hagenmueller; Stephan R Kuenzel; Stefanie Meyer-Roxlau; Martin Kramer; Samuel Sossalla; Lorenz H Lehmann; Susanne Kämmerer; Johannes Backs; Ali El-Armouche
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-16       Impact factor: 11.205

Review 3.  Timing and Targeting of Treatment in Left Ventricular Hypertrophy.

Authors:  Deokhwa Nam; Erin L Reineke
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Jan-Mar

4.  Cardiospecific deletion of αE-catenin leads to heart failure and lethality in mice.

Authors:  Volodymyr V Balatskyi; Larysa L Macewicz; Ana-Maria Gan; Sergii V Goncharov; Paulina Pawelec; Georgiy V Portnichenko; Tetiana Yu Lapikova-Bryginska; Viktor O Navrulin; Victor E Dosenko; Adam Olichwier; Pawel Dobrzyn; Oksana O Piven
Journal:  Pflugers Arch       Date:  2018-06-20       Impact factor: 3.657

5.  Targeting MRTF/SRF in CAP2-dependent dilated cardiomyopathy delays disease onset.

Authors:  Yao Xiong; Kenneth Bedi; Simon Berritt; Bennette K Attipoe; Thomas G Brooks; Kevin Wang; Kenneth B Margulies; Jeffrey Field
Journal:  JCI Insight       Date:  2019-03-21

Review 6.  Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.

Authors:  Rui Guo; Sreejayan Nair
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-24       Impact factor: 5.187

Review 7.  Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease.

Authors:  Alexander T Mikhailov; Mario Torrado
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

8.  Cardiac fibroblast transcriptome analyses support a role for interferogenic, profibrotic, and inflammatory genes in anti-SSA/Ro-associated congenital heart block.

Authors:  Robert M Clancy; Androo J Markham; Tanisha Jackson; Sara E Rasmussen; Miroslav Blumenberg; Jill P Buyon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-06-16       Impact factor: 4.733

9.  Ufm1-Specific Ligase Ufl1 Regulates Endoplasmic Reticulum Homeostasis and Protects Against Heart Failure.

Authors:  Jie Li; Guihua Yue; Wenxia Ma; Aizhen Zhang; Jianqiu Zou; Yafei Cai; Xiaoli Tang; Jun Wang; Jinbao Liu; Honglin Li; Huabo Su
Journal:  Circ Heart Fail       Date:  2018-10       Impact factor: 8.790

Review 10.  Myocardial plasticity: cardiac development, regeneration and disease.

Authors:  Joshua Bloomekatz; Manuel Galvez-Santisteban; Neil C Chi
Journal:  Curr Opin Genet Dev       Date:  2016-08-04       Impact factor: 5.578

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.